EZH2 alterations in follicular lymphoma: biological and clinical correlationsBlood Cancer Journal - Tập 7 Số 4 - Trang e555-e555
Sarah Huet, Luc Xerri, Bruno Tesson, Sylvain Mareschal, Sébastien Taix, Lénaïg Mescam-Mancini, Emilie Sohier, Marjorie Carrère, Julien Lazarovici, Olivier Casasnovas, Laurie Tonon, Sandrine Boyault, Sandrine Hayette, Corinne Haïoun, Bettina Fabiani, Alain Viari, Fabrice Jardin, Gilles Salles
AbstractThe histone methyltransferase EZH2 has an essential role in the
development of follicular lymphoma (FL). Recurrent gain-of-function mutations
inEZH2have been described in 25% of FL patients and induce aberrant methylation
of histone H3 lysine 27 (H3K27). We evaluated the role ofEZH2genomic gains in FL
biology. Using RNA sequencing, Sanger sequencing and SNP-arrays, the mutation
status, cop... hiện toàn bộ
IL-10 induces the development of immunosuppressive CD14+HLA-DRlow/− monocytes in B-cell non-Hodgkin lymphomaBlood Cancer Journal - Tập 5 Số 7 - Trang e328-e328
B Xiu, Yi Lin, D M Grote, Steven C. Ziesmer, Michael P. Gustafson, Meridean Maas, Z. Zhang, Allan B. Dietz, Luis F. Porrata, Anne J. Novak, A-B Liang, Z-Z Yang, S. Ansell
AbstractThe biological role of monocytes and macrophages in B-cell non-Hodgkin
lymphoma (NHL) is not fully understood. We have previously reported that
monocytes from patients with B-cell NHL have an immunosuppressive
CD14+HLA-DRlow/− phenotype that correlates with a poor prognosis. However, the
underlying mechanism by which CD14+HLA-DRlow/− monocytes develop in lymphoma is
unknown. In the present... hiện toàn bộ
NPM-ALK mediates phosphorylation of MSH2 at tyrosine 238, creating a functional deficiency in MSH2 and the loss of mismatch repairBlood Cancer Journal - Tập 5 Số 5 - Trang e311-e311
Kathleen M. Bone, P Wang, Fang Wu, Chenming Wu, L Li, Julinor Bacani, Susan E. Andrew, Rai‐Hua Lai
AbstractThe vast majority of anaplastic lymphoma kinase-positive anaplastic
large cell lymphoma (ALK+ALCL) tumors express the characteristic oncogenic
fusion protein NPM-ALK, which mediates tumorigenesis by exerting its
constitutive tyrosine kinase activity on various substrates. We recently
identified MSH2, a protein central to DNA mismatch repair (MMR), as a novel
binding partner and phosphoryla... hiện toàn bộ
Myelofibrosis Treatment Algorithm 2018Blood Cancer Journal - Tập 8 Số 8
Ayalew Tefferi, Paola Guglielmelli, Animesh Pardanani, Alessandro M. Vannucchi
AbstractTwo novel prognostic systems for primary myelofibrosis (PMF) were
recently unveiled: GIPSS (genetically inspired prognostic scoring system) and
MIPSS70 (mutation-enhanced international prognostic scoring system for
transplant-age patients). GIPSS is based exclusively on genetic markers:
mutations and karyotype. MIPSS70 includes mutations and clinical risk factors.
In its most recent adapta... hiện toàn bộ
Staphylococcus aureus enterotoxins induce FOXP3 in neoplastic T cells in Sézary syndromeBlood Cancer Journal - Tập 10 Số 5
Andreas Willerslev-Olsen, Terkild B. Buus, Claudia Nastasi, Edda Blümel, Maria Gluud, Charlotte M. Bonefeld, Carsten Geisler, Lise M. Lindahl, Maarten H. Vermeer, Mariusz A. Wasik, Lars Iversen, Jürgen C. Becker, Mads Hald Andersen, Lise Mette Rahbek Gjerdrum, Ivan V. Litvinov, Thomas Litman, Thorbjørn Krejsgaard, Anders Woetmann, Niels Ødum
AbstractSézary syndrome (SS) is a heterogeneous leukemic subtype of cutaneous
T-cell lymphoma (CTCL) with generalized erythroderma, lymphadenopathy, and a
poor prognosis. Advanced disease is invariably associated with severe immune
dysregulation and the majority of patients die from infectious complications
caused by microorganisms such as,Staphylococcus aureus, rather than from the
lymphoma per s... hiện toàn bộ
Autocrine insulin-like growth factor 1 and stem cell factor but not interleukin 6 support self-renewal of human myeloma cellsBlood Cancer Journal - Tập 3 Số 6 - Trang e120-e120
David Chiron, Sophie Maïga, Sylvanie Surget, Géraldine Descamps, Patricia Gomez‐Bougie, Sory Traoré, Nelly Robillard, Philippe Moreau, Steven Le Gouill, R Bataille, Martine Amiot, Catherine Pellat‐Deceunynck
CAR-T cell therapy: current limitations and potential strategiesBlood Cancer Journal - Tập 11 Số 4
Robert C. Sterner, Rosalie M. Sterner
AbstractChimeric antigen receptor (CAR)-T cell therapy is a revolutionary new
pillar in cancer treatment. Although treatment with CAR-T cells has produced
remarkable clinical responses with certain subsets of B cell leukemia or
lymphoma, many challenges limit the therapeutic efficacy of CAR-T cells in solid
tumors and hematological malignancies. Barriers to effective CAR-T cell therapy
include sev... hiện toàn bộ